Comments

InMed Pharmaceuticals Stock Guidance

INMNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$1.33
0.1310.83%
Last update: Dec 18, 9:29 AM
OverviewNewsEarningsInsider TradesShort InterestStock Report

InMed Pharmaceuticals Stock Guidance | NASDAQ:INM | Benzinga

InMed Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
InMed Pharmaceuticals Inc (INM) does not provide guidance data

FAQ

Q

What is the most recent guidance for InMed Pharmaceuticals (INM)?

A

There have been no specific sales or earnings guidance reported for InMed Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
$0.87
1.27%
SciSparc Ltd
NASDAQ:SPRC
$1.60
1.92%
Akanda Corp
NASDAQ:AKAN
$0.78
5.16%
Jaguar Health Inc
NASDAQ:JAGX
$1.16
-2.94%
Aspire Biopharma Holdings Inc
NASDAQ:ASBPW
$0.02
3.83%
No data available
Redhill Biopharma Ltd
NASDAQ:RDHL
$1.16
2.74%
PainReform Ltd
NASDAQ:PRFX
$0.98
-2.44%
Lexaria Bioscience Corp
NASDAQ:LEXXW
$0.04
-41.26%
No data available
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved